Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR IN PATIENTS WITH HCV GENOTYPE 5 OR 6 INFECTION: AN INTEGRATED ANALYSIS OF PHASE 2 AND 3 STUDIES Yao, B. B., Asselah, T., Frederick, L., Schnell, G., Kowdley, K., Kwo, P. Y., Poordad, F., Kinh Nguyen, Lee, S. S. BMJ PUBLISHING GROUP. 2019: A146–A147
View details for DOI 10.1136/gutjnl-2019-IDDFabstracts.285
View details for Web of Science ID 000472085300282